Abstract
Invention relates to medical and pharmaceutical industry and particularly to the use of diarylheptanoid compound 1,7-bis-(3,4-dihydroxyphenyl)-heptane-3’,5-O-β-D-xylopyranozide for improving acitvity of phagocytes.
Translated title of the contribution | Līdzeklis fagocitārās aktivitātes paaugstināšanai |
---|---|
Original language | Latvian |
Patent number | 14361 |
IPC | A61K31/12,A61P37/00 |
Priority date | 10/03/11 |
Filing date | 10/03/11 |
Publication status | Published - 20 Nov 2011 |
Keywords*
- improving acitvity of phagocytes
Field of Science*
- 3.2 Clinical medicine
Patent expiration date
- 01.10.2020